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Incerto: Um Estudo Retrospetivo de 23 Doentes      
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RESUMO – ,QWURGXomR As lesões melanocíticas podem apresentar características histológicas que impossibilitam a sua 
classificação de forma dicotómica como benignas ou malignas. Estas lesões, designadas proliferações melanocíticas de 
potencial maligno incerto, frequentemente apresentam características limítrofes entre nevo benigno e melanoma maligno, 
o que reflete o seu potencial biológico indeterminado. 0pWRGRV Com o objetivo de caracterizar a população de prolife-
rações melanocíticas de potencial maligno incerto diagnosticadas no nosso centro entre 2007 e 2017, foram analisados 
relatórios histopatológicos de lesões melanocíticas classificadas, neste período, como displásicas ou malignas. 5HVXOWDGRV
Identificaram-se 23 lesões (4,3%) com características histopatológicas borderline ou de potencial maligno incerto. A média 
de idades dos doentes foi de 34,8 anos. Dezasseis lesões (69,6%) foram observadas por um segundo patologista, com dis-
cordância interobservador em 25% dos casos. O tratamento mais frequentemente realizado foi a excisão alargada, com 
grande variabilidade no que concerne às margens cirúrgicas. Realizou-se biopsia de gânglio sentinela em dois doentes, 
que se viriam a revelar negativas. O tempo de follow-up mediano foi de 22 meses, não se verificando recidiva de nenhuma 
lesão tratada. 'LVFXVVmR A controvérsia do tema estende-se desde a natureza e classificação destas lesões até ao seu tra-
tamento. Com este trabalho foi possível observar a variabilidade quanto à caracterização histológica destas lesões, assim 
como ao seu tratamento. No entanto, a inexistência de recidivas ou mortes atribuíveis à doença corrobora o seu frequente 
carácter benigno e excelente prognóstico. 
PALAVRAS-CHAVE – Lesões Pré-Cancerosas; Melanocitos; Melanoma; Neoplasias da Pele; Nevo Pigmentado.
Melanocytic Proliferations of Uncertain Malignant 
Potential: A Retrospective Study of 23 patients 
ABSTRACT – ,QWURGXFWLRQ Melanocytic lesions may present with several histologic features that make them impossible to 
classify in a dichotomous way, as benign or malignant. Such lesions, designated as melanocytic proliferations of uncertain 
malignant potential, frequently show borderline features between benign nevus and malignant melanoma, reflecting their 
undetermined biological potential. 0HWKRGV In order to characterize melanocytic proliferations of uncertain malignant potential 
diagnosed at our center between 2007 and 2017, histopathological reports of melanocytic lesions classified, in this period, as 
either dysplastic or malignant were analyzed. 5HVXOWV Twenty-three lesions (4.3%) with borderline histopathological features or 
uncertain malignant potential were identified. The mean patient age was 34.8 years. Sixteen lesions (69.6%) were observed by 
a second pathologist, with an inter-observer disagreement on 25%. The most frequently performed treatment was wide excision, 
with large variability regarding the surgical margins. A sentinel lymph node biopsy was performed in two patients, both being 
negative. The median follow-up time was 22 months, and there was no recurrence of any treated lesion. 'LVFXVVLRQ The 
controversy of this subject extends from the nature and classification of these lesions to their treatment. With this study we were 
able to verify the variability regarding their histologic characterization, as well as their treatment. However, the inexistence of 
recurrences and deaths attributable to the disease corroborates their frequently benign character and excellent prognosis. 
KEYWORDS – Melanocytes; Melanoma; Nevus, Pigmented; Precancerous Conditions; Skin Neoplasms.
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INTRODUCTION
For many years, from a histological point of view, the 
dominant paradigm was to classify melanocytic lesions in a 
dichotomous way, either as benign or malignant. However, 
these lesions may have features that give the diagnosis a cer-
tain degree of uncertainty. The pathologist is frequently con-
fronted with lesions with borderline characteristics between 
benign simulants and malignant melanoma due to ambi-
guous diagnostic criteria and inter-observer discordance.
We define melanocytic proliferations of uncertain malig-
nant potential (MPUMP) as those that cannot be histologically 
classified as benign or malignant, presenting ambiguous 
features that reflect their undetermined biological potential.
These lesions can be divided into two generic categories: 
superficial - superficial atypical melanocytic proliferations of 
unknown significance (SAMPUS) and deep - melanocytic tu-
mors of uncertain malignant potential (MELTUMP). In the first 
category we include predominantly junctional lesions and 
lesions confined to the epidermis and papillary dermis, wi-
thout evidence of tumor proliferation or mitoses in the der-
mal component. As such, the risk of metastasis is expected to 
be low and the prognosis excellent. The differential diagnosis 
is made mainly between in situ melanoma and dysplastic 
junctional nevus. The second category, MELTUMP, consists 
of lesions with a dermal tumor component, therefore with a 
potential local and distant metastatic capacity. Due to their 
atypical characteristics, the diagnosis of invasive melanoma 
cannot be safely discarded. In this category we include atypi-
cal Spitz nevus, deep penetrating nevus, cellular blue nevus 
and nevoid melanoma.1
We henceforth tried to characterize and review MPUMP 
diagnosed at our department.
METHODS
In this study, we performed a retrospective analysis of 
MPUMP diagnosed in our department between 2007 and 
2017. To perform this task, a search in the database of 
the Pathology Department of this center was carried out. 
Histopathological reports coded, according to SNOMED 
classification, as "Dysplastic Nevus", "Melanoma in situ", "Ma-
lignant melanoma" and "Epithelioid or Spindle Cell Nevus" 
were searched. The lesions described on the histology re-
port as having borderline features, such as cytoarchitectural 
atypia, pagetoid spread, deep mitosis, asymmetry or loss of 
vertical maturation were included. By consulting the clinical 
file and histology report, variables such as demographic 
characteristics (age and gender), lesion characteristics and 
its anatomical location, histopathological features, treatment 
performed, follow-up time and recurrences were extracted.
Categorical variables are presented with absolute and 
relative frequency and continuous variables with mean and 
standard deviation (SD) or with median and interquartile 
range (IQR) for variables that do not follow a normal distri-
bution. The normal distribution was verified using the Shapi-
ro-Wilk test or skewness and kurtosis values.
One-way ANOVA was used to compare patient age and 
follow-up times for each type of lesion. Chi-square test was 
used to evaluate the relation between lesion classification 
and a second pathological observation.
All p values reported are two-tailed, with a p value lower 
than 0.05 indicating statistical significance. Tests were con-
ducted using SPSS software (IBM Analytics), version 23.0.
RESULTS
Five hundred and thirty nine histopathological reports 
coded as "Dysplastic Nevus", "Melanoma in situ", "Malig-
nant Melanoma" or "Epithelioid or Spindle Cell Nevus" were 
analyzed. Twenty three lesions (4.3%) with characteristics of 
uncertain malignant potential were identified. The majority 
(60.3%) of these lesions were diagnosed in the last 3 years 
of analysis.
Lesional features
Eight (34.8%) superficial lesions and 15 (65.2%) deep le-
sions were identified (Table 1). Most of the superficial lesions 
were classified by the pathologist as SAMPUS and most of the 
deep lesions were classified as atypical Spitz nevus. Eleven 
(47.8%) lesions were reported to have a spitzoid phenotype, 
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Table 1 - Histologic characteristics of the lesions. 
6XSHUÀFLDO Deep Total p value
+LVWRORJLFFODVVLÀFDWLRQQ
%RUGHUOLQHG\VSODVWLFQHYXV
6$0386
$W\SLFDO6SLW]QHYXV
0(/7803
'HHSSHQHWUDWLQJQHYXV
3 (37.5)
5 (62.5)
0
0
0
0
0
11 (73.3)
3 (20.0)
1 (6.7)
3 (13.0)
5 (21.7)
11 (47.8)
3 (13.0)
1 (4.3
---
+LVWRORJLFDOFKDUDFWHULVWLFVQ
&\WRDUFKLWHFWXUDODW\SLD
3DJHWRLGVSUHDG
'HHSPLWRVLV
'HUPDOLQIODPPDWRU\LQILOWUDWH
/RVVRIYHUWLFDOPDWXUDWLRQ
5 (62.5)
6 (75.0)
0
6 (75.0)
0
15 (100.0)
8 (53.3)
3 (20.0)
10 (66.7)
2 (13.3)
20 (87.0)
14 (60.9)
3 (13.0)
16 (69.6)
2 (8.7)
-
6HFRQGREVHUYDWLRQQ 2 (25.0) 14 (93.3) 16 (69.6) 0.02
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defined as epithelioid or fusiform cellular morphology, and 
were found exclusively on deep lesions.
The most frequent histopathological features reported 
by the pathologist were cytoarchitectural atypia in 87.0%, 
dermal inflammatory infiltrate in 70.0%, pagetoid spread in 
60.9%, deep mitoses in 13.0% and loss of vertical matura-
tion in 8.7%.
Sixteen (70.0%) lesions, 14/15 deep lesions (93.3%) and 
2/8 superficial lesions (25%) were observed by a second pa-
thologist specialized in melanocytic tumors, who in 25.0% of 
cases had a different opinion concerning the nature of the 
lesions (two SAMPUS and one MELTUMP initially classified 
as dysplastic nevi as well as one atypical Spitz nevus initially 
classified as spitzoid melanoma).
Population
Eight (34.8%) lesions occurred in male patients and 15 
(65.2%) in females (Table 2), with no predilection of gender 
for any histopathological type of lesion.
The mean patient’s age was 34.8 (SD 15.6) years, ran-
ging from 5 to 65 years. The mean age of patients with spit-
zoid lesion phenotype was 27.2 (SD 11.2) years, while that 
of non-spitzoid was 41.8 (SD 16.2) years (p = 0.02). There 
was no significant difference on patient’s age in the other 
groups of lesions.
As to lesion location, the most frequent sites were the 
lower limbs (43.5%), followed by the trunk (34.8%), head 
and neck (13.0%), with no particular association between the 
type of lesion and localization.
Treatment
For superficial lesions, wide excision with a 5 mm margin 
was performed in six out of eight cases (75%) and 10 mm mar-
gin in the other two cases. For deep lesions, the most frequent 
approach was narrow excision (7/15 cases, 47%), followed by 
wide excision with a 5 mm margin (5/15, 33%) and wide exci-
sion with a 10 mm margin (3/15, 20%) (Table 3). 
Two patients with deep lesions underwent a sentinel 
lymph node biopsy, which were negative in both cases.
Follow-up
To date, 10 (43.5%) patients remain under surveillance 
at our department, three (13.0%) are followed at another 
center and 10 (43.5%) were lost during follow-up (Table 4). 
Patients with superficial lesions were followed for a median 
period of 10.0 months (min. 6 months, max. 36 months), 
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Table 2 - Demographic characteristics and lesion location. 
6XSHUÀFLDO Deep Total p value
6H[Q
0DOH
)HPDOH
$JH0HDQ6'\HDUV
4 (50.0)
4 (50.0)
43.0 (14.6)
4 (26.7)
11 (73.3)
30.5 (14.8)
8 (34.8)
15 (65.2)
34.8 (15.6)
0.065
/RFDWLRQQ
+HDGDQGQHFN
7UXQN
8SSHUOLPEV
/RZHUOLPEV
0
5 (62.5)
0
3 (37.5)
3 (20.0)
3 (20.0)
2 (13.3)
7 (46.7)
3 (13.0)
8 (34.8)
2 (8.7)
10 (43.5)
Table 3 - Treatment performed. 
6XSHUÀFLDO Deep Total
7UHDWPHQWSHUIRUPHGQ
1DUURZH[FLVLRQ
:LGHH[FLVLRQZLWKPPPDUJLQV
:LGHH[FLVLRQZLWKPPPDUJLQV
0
6 (75.0)
2 (25.0)
7 (46.7)
5 (33.3)
3 (20.0)
7 (30.4)
11 (47.8)
5 (21.7)
6HQWLQHOO\PSKQRGHELRSV\Q
3RVLWLYH
1HJDWLYH
0
0
0
2 (100.0)
0
2 (100.0)
Table 4 - Follow-up time and recurrences. 
6XSHUÀFLDO Deep Total p value
Follow-up, median (IQR), months 10.0 (21.0) 22.0 (25.0) 22.0 (20.0) 0.506
Local or distant recurrence 0 0 0
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while those patients with deep lesions were followed for 22.0 
months (min. 0 months, max. 84 months) (p = 0.23). Ove-
rall, the median follow-up time was 22.0 months (IQR 20.0, 
range 0 to 84 months).
During the follow-up period, no local, regional or distant 
recurrences were identified.
DISCUSSION
Although rare, the number of lesions diagnosed as ha-
ving uncertain malignant potential has been increasing. In 
our population, 60.9% of the lesions were diagnosed in 
the last 3 years of the study. In our opinion, the increasing 
diagnosis does not reflect an increase in the prevalence 
of these lesions, but rather a greater awareness of these 
entities.
The mean age of the patients (34.8 years) is in agree-
ment with similar series.2,3 Furthermore, lesions with 
spitzoid phenotype were found in significantly younger pa-
tients, corroborating the already available data showing 
their increased prevalence in this population.4
Regarding treatment, it was possible to verify a large 
variability in the approach to these lesions, expressed by 
the different excision margins used on lesions with simi-
lar characteristics, which reflects the absence of studies 
and guidelines on this subject. Interestingly, superficial le-
sions and, therefore, with no or low expected metastatic 
potential, were subjected to more aggressive approaches, 
such as excision with 5 mm margins. This discrepancy may 
be related to a greater number of deep lesions that were 
classified as "melanocytic nevus" at the time of the clinical 
diagnosis. We presume that under a clinical impression of 
benignity, clinicians selected less aggressive approaches.
In this study, only two patients underwent sentinel lymph 
node biopsy. Meyers et al5 performed a sentinel lymph 
node biopsy in 31 patients with MELTUMP, five (16%) of 
which were positive. Lallas et al6 have demonstrated that 
this may be positive in up to 31% of patients with atypical 
Spitz nevi, although mortality is very low. In essence, a po-
sitive sentinel lymph node biopsy does not seem to predict 
a more aggressive or unfavorable prognosis, and its exe-
cution is discouraged by some authors.7
During follow-up we found no local/distant recurren-
ces or deaths attributable to the disease. Although with a 
relatively short follow-up period, this study corroborates 
previous studies where patients were followed for longer 
periods, confirming the good prognosis of these entities.2,5,8 
Only 70% of these neoplasms were observed by a se-
cond pathologist, which, in our view, is insufficient. When 
confronted with a situation of uncertainty, a second ob-
servation and consequent discussion may lead to the re-
duction of its subjective side and diagnostic error. But a 
second observation is, indeed, associated with a high inter-
-observer discordance on the nature of the lesion. This is 
ultimately a reflection of the pathologists’ criteria and their 
experience and a further indicator of the importance of this 
discussion.9
This study is not without limitations. Perhaps the most im-
portant ones are the low sample size (n=23). The authors, 
however, feel these numbers are still significant, as they ac-
count for 10 years of MPUMP diagnosed at this center, given 
their low rate of occurrence. Another important limitation is 
the fact that the histology report was the sole source of infor-
mation regarding lesion characteristics, as no slides were re-
viewed for this study. Other potential weaknesses include the 
non-detection of some lesions when searching the database, 
due to coding errors or the complete lack of coding, and the 
short median follow-up time (22 months). Despite these limi-
tations, this is one of the few studies analyzing the diagnosis 
and management of MPUMP (both deep and superficial), and 
the first performed in a Portuguese population.
To conclude, in this study we were able to verify the 
benign behavior of these lesions within the relatively short 
term follow-up, given their extremely low rate of recurren-
ces and deaths attributable to the disease. However, the 
inexistence of clinical guidelines for this subject leads to 
a high variability on their management, expressed by the 
different treatment approaches for similar lesions. Further 
studies are needed to clarify the biologic behavior of these 
entities as well as their best management strategy.
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